Biotech SF: Rituxan

Showing posts with label Rituxan. Show all posts

Friday, January 28, 2011

Genentech's Rituxan wins FDA approval for advanced follicular lymphoma

Sunday, December 5, 2010

Cancer study boosts Genentech's Rituxan

Some blood cancer patients could use Genentech Inc.’s venerable drug Rituxan earlier to hold the cancer at bay and even shrink tumors.

Subscribe to: Posts (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.